These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 36944188)

  • 1. Attenuation of cancer proliferation by suppression of glypican-1 and its pleiotropic effects in neoplastic behavior.
    Cheng F; Hansson VC; Georgolopoulos G; Mani K
    Oncotarget; 2023 Mar; 14():219-235. PubMed ID: 36944188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glypican-1, -3, -5 (GPC1, GPC3, GPC5) and Hedgehog Pathway Expression in Oral Squamous Cell Carcinoma.
    Schlaepfer Sales CB; Guimarães VSN; Valverde LF; Dias RB; Freitas RD; Siquara da Rocha LO; Coelho de Miranda M; Vilas Bôas DS; Gonçalves Agra IM; Dos Santos JN; Gurgel Rocha CA
    Appl Immunohistochem Mol Morphol; 2021 May-Jun 01; 29(5):345-351. PubMed ID: 33512817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GPC1 Is Associated with Poor Prognosis and Treg Infiltration in Colon Adenocarcinoma.
    Liu Y; Ren H; Yang MQ; Li JY
    Comput Math Methods Med; 2022; 2022():8209700. PubMed ID: 36158119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated glypican-1 expression is associated with an unfavorable prognosis in pancreatic ductal adenocarcinoma.
    Lu H; Niu F; Liu F; Gao J; Sun Y; Zhao X
    Cancer Med; 2017 Jun; 6(6):1181-1191. PubMed ID: 28440066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-glypican-1 antibody-drug conjugate exhibits potent preclinical antitumor activity against glypican-1 positive uterine cervical cancer.
    Matsuzaki S; Serada S; Hiramatsu K; Nojima S; Matsuzaki S; Ueda Y; Ohkawara T; Mabuchi S; Fujimoto M; Morii E; Yoshino K; Kimura T; Naka T
    Int J Cancer; 2018 Mar; 142(5):1056-1066. PubMed ID: 29055044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of Annexin A2 promotes proliferation by forming a Glypican 1/c-Myc positive feedback loop: prognostic significance in human glioma.
    Li X; Nie S; Lv Z; Ma L; Song Y; Hu Z; Hu X; Liu Z; Zhou G; Dai Z; Song T; Liu J; Wang S
    Cell Death Dis; 2021 Mar; 12(3):261. PubMed ID: 33712571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A glypican-1-targeted antibody-drug conjugate exhibits potent tumor growth inhibition in glypican-1-positive pancreatic cancer and esophageal squamous cell carcinoma.
    Munekage E; Serada S; Tsujii S; Yokota K; Kiuchi K; Tominaga K; Fujimoto M; Kanda M; Uemura S; Namikawa T; Nomura T; Murakami I; Hanazaki K; Naka T
    Neoplasia; 2021 Sep; 23(9):939-950. PubMed ID: 34332450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glypican 1 stimulates S phase entry and DNA replication in human glioma cells and normal astrocytes.
    Qiao D; Meyer K; Friedl A
    Mol Cell Biol; 2013 Nov; 33(22):4408-21. PubMed ID: 24019070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glypican-1 targeted antibody-based therapy induces preclinical antitumor activity against esophageal squamous cell carcinoma.
    Harada E; Serada S; Fujimoto M; Takahashi Y; Takahashi T; Hara H; Nakatsuka R; Sugase T; Nishigaki T; Saito Y; Hiramatsu K; Nojima S; Mitsuo R; Ohkawara T; Morii E; Mori M; Doki Y; Kaneda Y; Naka T
    Oncotarget; 2017 Apr; 8(15):24741-24752. PubMed ID: 28445969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glypican-1 Promotes Tumorigenesis by Regulating the PTEN/Akt/β-Catenin Signaling Pathway in Esophageal Squamous Cell Carcinoma.
    Li J; Chen Y; Zhan C; Zhu J; Weng S; Dong L; Liu T; Shen X
    Dig Dis Sci; 2019 Jun; 64(6):1493-1502. PubMed ID: 30730015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic pan-cancer analyses of the potential function of the Golgi scaffold protein PAQR3.
    Ling ZN; Hong LL; Wu J; Ling ZQ
    Sci Rep; 2024 Feb; 14(1):3030. PubMed ID: 38321173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of glypican 3 inhibits growth of hepatocellular carcinoma cells through up-regulation of TGF-β2.
    Sun CK; Chua MS; He J; So SK
    Neoplasia; 2011 Aug; 13(8):735-47. PubMed ID: 21847365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of glypican-1 expression with TGF-beta, BMP, and activin receptors in pancreatic ductal adenocarcinoma.
    Kayed H; Kleeff J; Keleg S; Jiang X; Penzel R; Giese T; Zentgraf H; Büchler MW; Korc M; Friess H
    Int J Oncol; 2006 Nov; 29(5):1139-48. PubMed ID: 17016645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GPC1 promotes the growth and migration of colorectal cancer cells through regulating the TGF-β1/SMAD2 signaling pathway.
    Lu F; Chen S; Shi W; Su X; Wu H; Liu M
    PLoS One; 2022; 17(6):e0269094. PubMed ID: 35671267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers.
    Wang N; Zhu L; Wang L; Shen Z; Huang X
    Comput Struct Biotechnol J; 2022; 20():3106-3119. PubMed ID: 35782736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Glypican proteoglycans show intrinsic interactions with Wnt-3a in human prostate cancer cells that are not always associated with cascade activation.
    de Moraes GFA; Listik E; Justo GZ; Vicente CM; Toma L
    BMC Mol Cell Biol; 2021 May; 22(1):26. PubMed ID: 33947326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High levels of serum glypican-1 indicate poor prognosis in pancreatic ductal adenocarcinoma.
    Zhou CY; Dong YP; Sun X; Sui X; Zhu H; Zhao YQ; Zhang YY; Mason C; Zhu Q; Han SX
    Cancer Med; 2018 Nov; 7(11):5525-5533. PubMed ID: 30358133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The molecular feature of macrophages in tumor immune microenvironment of glioma patients.
    Zhang H; Luo YB; Wu W; Zhang L; Wang Z; Dai Z; Feng S; Cao H; Cheng Q; Liu Z
    Comput Struct Biotechnol J; 2021; 19():4603-4618. PubMed ID: 34471502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immuno-PET and Targeted α-Therapy Using Anti-Glypican-1 Antibody Labeled with
    Watabe T; Kabayama K; Naka S; Yamamoto R; Kaneda K; Serada S; Ooe K; Toyoshima A; Wang Y; Haba H; Kurimoto K; Kobayashi T; Shimosegawa E; Tomiyama N; Fukase K; Naka T
    J Nucl Med; 2023 Dec; 64(12):1949-1955. PubMed ID: 37827841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The BRCAness Landscape of Cancer.
    Guo M; Wang SM
    Cells; 2022 Dec; 11(23):. PubMed ID: 36497135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.